Dave Capraro is categorized under Veterinary Biological Products in Cocoa Beach, FL and active since 2010.
Dave Capraro was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Veterinary Biological Products business, which does work in the B2B market, and is classified as a Veterinary Biological Products, under code number 325414 by the NAICS.
If you are seeking more information, feel free to contact David Capraro at the company’s single location by writing to 150 East Columbia Lane # 2, Cocoa Beach, Florida FL 32931 or by phoning (321) 406-1618. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Dave Capraro |
Contact Person: | David Capraro |
Address: | 150 East Columbia Lane # 2, Cocoa Beach, Florida 32931 |
Phone Number: | (321) 406-1618 |
Website Address: | oceananimalhospital.com |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Veterinary Biological Products |
SIC Code: | 2836 |
NAICS Code: | 325414 |
Share This Business: |
Dave Capraro was started in 2010 to provide professional Veterinary Biological Products under the SIC code 2836 and NAICS code 325414. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact David Capraro for inquiries that concern Dave Capraro by calling the company number (321) 406-1618, as your correspondence is most welcome. Additionally, the physical location of the single location of Dave Capraro can be found at the coordinates 28.358768,-80.606712 as well as the street address 150 East Columbia Lane # 2 in Cocoa Beach, Florida 32931.
For its online presence, you may visit Dave Capraro’s website at oceananimalhospital.com and engage with its social media outlets through on Twitter and on Facebook.